Express Pharma

Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData

The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or hydroxychloroquine (HCQ)

0